Category | Instrument name | Subscale/domains | No. items | Target Group (age, years) | Diseases assessed | Ref |
---|---|---|---|---|---|---|
Ataxia | Quality of Life in Essential Tremor Questionnaire (QUEST) | Communication, work and finances, hobbies and leisure, physical, psychosocial | 30 | ≥ 18 | Essential tremor | [37] |
Multiple System Atrophy Quality of Life questionnaire (MSA-QoL) | Motor, nonmotor, emotional/social functioning | 40 | ≥ 18 | Multiple system atrophy | [38] | |
Cardiomyopathy | Kansas City Cardiomyopathy Questionnaire (KCCQ-12) | Physical limitation, symptom frequency, quality of life, and social limitation | 12 | No reference | Cardiomyopathy | [39] |
Minnesota Living with Heart Failure Questionnaire (MLHFQ) | Physical impairment, emotional impairment | 21 | No specification ("elderly") | Heart failure | ||
Coagulopathy | Haemophilia-specific health-related quality of life questionnaire for adults (HAEMO-QoL-A) | Physical functioning, role functioning, worry, consequences of bleeding, emotional impact, treatment concerns | 41 | ≥ 18 | Haemophilia | [42] |
Haemophilia-specific health-related quality of life questionnaire—short form (HAEMO-QoL-SF) | Physical health, feelings, view of yourself, family, friends, other people, sports & school, dealing with haemophilia and treatment | 35 | 4–17 (4–7; 8–17) | Haemophilia | [43] | |
Canadian Haemophilia Outcomes-Kids’ Life Assessment Tool (CHO-KLAT) | Treatment, physical health, family, future, feelings, understanding of haemophilia, other people and friends, and control over your life | 35 | 4–18 | Haemophilia | [44] | |
Dysarthria | Quality of Life in the Dysarthric Speaker (QOL-Dys) | Speech characteristics of the word, situational difficulty, compensatory strategies, perceived reactions of others | 40 | ≥ 18 | Dysarthria | |
Living with Neurologically Based Speech Difficulties (LwD) | Comunication problems related primarily to speech, comunication problems related primarily to language/cognition, comunication problems related primarily to fatigue, effects of emotions, effects of different persons, effects of different situations, consequences of my difficulties in communicating, what contributes to the changes in the ways I communicate, communicating like I would want to, how do I perceive changes and the possibility to alter my ways of speaking | 50 | ≥ 18 | Parkinson disease | [47] | |
Dysarthria impact profile (DIP) | The effects of dysarthria on me as a person; accepting my dysarthria; how i feel others react to my speech; how my dysarthria affects my communication with others | 52 | No reference | Dysarthria acquired through different diseases (e.g. multiple sclerosis, motor neuron discase, Parkinson disease, stroke, Friedreich ataxia) | [48] | |
Speech Handicap Index (SHI) | Psychosocial function; speech function | 30 | No reference | Oral and pharyngeal cancer | [49] | |
Dysphagia | Swallowing Quality Of Life (SWAL-QOL) | Burden, eating duration, eating desire, food selection, communication, fear, mental health, social, fatigue, and sleep | 44 | ≥ 18 | Friedreich ataxia; laryngotracheal disease; dysphagia | |
Deglutition Handicap Index (DHI) | Physical, functional and emotional | 30 | ≥ 18 | Dysphagia | ||
Eating Assessment Tool (EAT-10) | Unidimensional | 10 | ≥ 18 | Dysphagia | ||
Dysphagia Handicap Index (DHI) | Physical, emotional, and functional problems | 25 | ≥ 18 | Dysphagia | [57] | |
Food Allergy | Food Allergy Quality of Life Questionnaire—Parent Form (FAQLQ-PF) | Emotional impact, food anxiety, social/dietary limitations | 30 | 0–12 (0–3; 4–6; 7–12) | Food allergy | [58] |
Celiac Disease-specific DUX questionnaire (CDDUX) | Communication, having celiac disease, scale diet | 12 | 8–18 (or their caregivers) | Celiac disease | [59] | |
Gastrointestinal problems | Short Inflammatory Bowel Disease Questionnaire (SIBDQ) | Bowel symptoms, systemic symptoms, emotional functioning, social functioning | 10 | ≥ 18 | Inflammatory bowel disease | [60] |
Inflammatory Bowel Disease Questionnaire (IBDQ)-9 | Total score | 9 | ≥ 18 | Inflammatory bowel disease | [61] | |
Irritable Bowel Syndrome Quality of Life Questionnaire (IBSQoL) | Emotional health, mental health, health belief, sleep, energy, physical functioning, diet, social role, physical role, and sexual relations | 30 | ≥ 18 | Irritable bowel syndrome | [62] | |
Irritable Bowel Syndrome Quality of Life (IBS-QOL) | Dysphoria, interference with activity, body image, health worry, food avoidance, social reaction, sexual, relationships | 34 | ≥ 18 | Irritable bowel syndrome, chronic functional constipation, inflammatory bowel disease | ||
Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQL) | Total score | 10 + 1 not scored | No reference | Gastroesophageal reflux disease | [65] | |
GastroIntestinal Quality of Life Index (GIQLI) | Core symptoms, physical items, psychological items, social items, disease-specific items | 36 | ≥ 18 | Gastrointestinal problems; type 2 diabetes mellitus; seveve obesity; post-Whipple surgery and postcholecystectomy | [66] | |
Scleroderma gastrointestinal tract 1.0 questionnaire (SSC-GIT 1.0) | Reflux/indigestion, diarrhea, constipation, pain, emotional well-being, social functioning | 52 | ≥ 18 | Systemic sclerosis | [67] | |
EORTC QLQ—Oesophageal Module 18 (OES18) | Dysphagia, eating, reflux, and pain plus 6 single items (swallowing saliva, choking, dry mouth, taste, cough, speech) | 18 | ≥ 18 | Dysphagia, esophageal eosinophilia, esophageal cancer | [68] | |
EORTC QLQ- Gastrointestinal Neuroendocrine Carninoid Module (GINET21) | Endocrine symptoms, GI symptoms, treatment-related symptoms, social functioning and disease-related worries plus 4 single-items (muscle and/or bone pain, body image, information and sexual functioning) | 21 | ≥ 18 | Gastroenteropancreatic neuroendocrine tumours | ||
Home parenteral nutrition-quality of life (HPN-QOL) | General health, ability to holiday or travel, coping, physical function, ability to eat and drink, employment, sexual function, and emotional function, body image, immobility, fatigue, sleep pattern, gastrointestinal symptoms, other pain, presence or absence of a stoma, financial issues, and weight | 47 | ≥ 17 | Chronic intestinal failure patients treated with home parenteral nutrition | ||
Izumo scale for abdominal symptom-related QOL | Heartburn, gastralgia, postprandial fullness, constipation, diarrhea | 15 | No reference | Type 2 diabetes mellitus; upper gastrointestinal symptoms, bone resorption and back pain in postmenopausal osteoporosis patients | [73] | |
Short Form-Nepean Dyspepsia Index (SF-NDI) | Interference with daily activities, knowledge/control, tension, work/study and eating/drinking | 10 | ≥ 18 | Irritable bowel syndrome | [74] | |
IBDQ-32 | Bowel symptoms, systemic symptoms, emotional function and social function | 32 | ≥ 18 | Irritable bowel syndrome, irritable pouch syndrome and inflammatory bowel disease (Crohn disease and ulcerative colitis) | [75] | |
IBDQ-36 | Bowel symptoms, systemic symptoms, functional impairment, emotional functioning, social impairment | 36 | ≥ 18 | Inflammatory bowel disease | [76] | |
Infections | Sino-Nasal Outcome Test (SNOT-22) | Rhinologic, extra-nasal rhinologic, and ear/facial symptoms, psychological and sleep dysfunction | 22 | ≥ 16 | Chronic rhinosinusitis | [77] |
Sino-Nasal Outcome Test (SNOT-20) | Rhinologic, extra-nasal rhinologic, and ear/facial symptoms, psychological and sleep dysfunction | 20 | ≥ 18 | Bronchiectasis, allergic fungal rhinosinusitis | [78] | |
Leicester Cough Questionnaire (LCQ) | Physical, psychological and social | 19 | ≥ 18 | Bronchiectasis | [79] | |
Kyphosis/Scoliosis | Scoliosis Research Society (SRS-30) | Function/activity, pain, self-image/appearance, mental health, satisfaction with management | 31 | 13–17, 18–64 | Scoliosis | [80] |
SRS-22; SRS-22r | Function/activity, pain, self-image/appearance, mental health, satisfaction with management | 22 | 13–17; 18–64 | Adolescent idiopathic scoliosis | ||
SRS-7 | Unidimensional | 7 | 13–18 | Adolescent idiopathic scoliosis | [83] | |
Early-Onset Scoliosis Questionnaire (EOSQ-24) | General health, pain/discomfort, pulmonary function, transfer, physical function, daily living, fatigue/energy level, emotion, parental impact, financial impact, satisfaction | 24 | 0–18 | Early-onset scoliosis | [84] | |
Scoliosis Quality of Life Index (SQLI) | Physical activity performance, back pain, self-esteem, moods & feelings, and satisfaction with management | 22 | 10–18 | Adolescent idiopathic scoliosis | [85] | |
The Italian Spine Youth Quality of Life questionnaire (ISYQOL) | Unidimensional | 20 | 10–18 | Adolescent idiopathic scoliosis | ||
Liver problems | Chronic Liver Disease Questionnaire for NAFLD and NASH (CLDQ NAFLD/NASH) | Abdominal symptoms, activity/energy, emotional health, fatigue, systemic symptoms, and worry | 36 | ≥ 18 | Non-alcoholic steatohepatitis | |
Chronic Liver Disease Questionnaire (CLDQ) | Fatigue, activity, emotional function, abdominal symptoms, systemic symptoms, and worry | 29 | ≥ 18 | Cirrhosis, hepatic encephalopathy, cholestatic liver diseases | [90] | |
Ophthalmological problems | National Eye Institute Visual Functioning Questionnaire—25 (NEI VFQ-25) | General vision, near vision, distance vision, driving, peripheral vision, color vision, ocular pain, general health, and vision-specific role difficulties, dependency, social function, and mental health | 25 | ≥ 18 | RLBP1 retinitis pigmentosa, Friedreich’s ataxia, myopia, hyperopia, astigmatism, nystagmus, strabismus, spinocerebellar ataxia, glaucoma | [91] |
National Eye Institute Refractive Error Quality of Life Instrument—42 (NEI RQL-42) | Clarity of vision, expectations, near vision, far vision, diurnal fluctuations, activity limitations, glare, symptoms, dependence on correction, worry, suboptimal correction, appearance, and satisfaction with correction | 42 | ≥ 18 | Myopia, astigmatism, hyperopia | [92] | |
VFS-plus | Unidimensional | 19 | ≥ 18 | Retinitis pigmentosa | [93] | |
Pediatric Eye Questionnaire (PedEyeQ) | Functional vision, bothered by eyes/vision, social, frustration/worry, eye care | 39–42 | < 18 (0–4; 5–11; 12–17) | Strabismus and anisometropia | [94] | |
Intermittent Exotropia Questionnaire (IXTQ) | Unidimensional | 12 | 5–17 (5–7; 8–17) | Intermittent exotropia, strabismus, children wearing spectacles | [95] | |
Adult Strabismus Quality of Life Questionnaire (AS-20) | Psychosocial and function | 20 | ≥ 18 | Epiretinal membrane, nondiplopic childhood-onset strabismus, strabismus, glaucoma, diplopia | [96] | |
Adult Strabismus Quality of Life Questionnaire—11 item (AS-11) | Unidimensional | 11 | ≥ 18 | Strabismus | [97] | |
Low Luminance Questionnaire (LLQ) | Driving, extreme lighting, mobility, emotional distress, general dim lighting, peripheral vision | 32 | ≥ 18 | RLBP1 Retinitis Pigmentosa | [98] | |
Questionnaire on the impact of strabismus on patient quality of life based on AS-20 from Ribeiro Gde B et al., 2014 | Psychosocial aspects and functional aspects | 20 | > 7 | Strabismus | [99] | |
College of Optometrists in Vision Development Quality of Life questionnaire (COVD QOL) | Somatic, physical/occupational, social, and psychological | 30 | > 7 | Intermittent central suppression of vision | [100] | |
8-question QoL live interview developed by Kothari M et al., 2009 | No reference | 8 | 4–16 | Strabismus | [101] | |
Vision Quality of Life Questionnaire by McKeon C et al., 1997 | Psychological well-being, perception of health, role functioning, physical health, visual function | 32 | 8–46 | Intermittent exotropia | [102] | |
Questionnaire for Evaluating Quality of Life of Pathologic Myopia Patients by Takashima T et al., 2001 | Vision-related daily tasks, social handicaps, emotional handicaps, leisure and support, cognition about disease, general well-being schedule, eye satisfaction, life satisfaction | 52 | ≥ 18 | Myopia | [103] | |
Amblyopia and Strabismus Questionnaire (A&SQ) | Distance estimation, visual disorientation, fear of losing the better eye, diplopia, and social contact and cosmetic problems | 26 | ≥ 18 | Amblyopia, small-angle diplopia, strabismus | [104] | |
Quality of Life Impact of Refractive Correction (QIRC) | Visual function, health concerns, well-being, convenience issues, symptoms, economic issues and cognitive issues | 20 | ≥ 16 | Myopia | [105] | |
10-item Neuro-Ophthalmic Supplement (NOS) to the NEI-VFQ-25 | Visual function and eye/lid appearance | 10 | ≥ 18 | Spinocerebellar ataxia | [106] | |
HRQOL questionnaire by Chen et al., 2015 | Visual function, psychosocial impact, social interaction and worries about vision | 16 | 7–12 | Amblyopia | [107] | |
Disease specific questionnaire based on the study of the Joint LASIK Study Task Force (Schallhorn et al., 2016) | Patient satisfaction, effect of vision on various activities, ocular discomfort and visual phenomena | 23 | ≥ 18 | Post laser in situ keratomileusis intervention | ||
Nystagmus-specific QOL questionnaire (NYS-29) | Personal and social functional and physical and environmental functional | 29 | ≥ 18 | Nystagmus | [111] | |
Quality-of-Life Scale for Myopia by Erickson et al., 2004 | Tolerance of compromise/symptom, psychological states, frequency of compromise/symptom, extraversion/introversion, cosmesis | 52 | ≥ 18 | Myopia | [112] | |
Osteopenia | Short Osteoporosis Quality of Life Questionnaire (ECOS-16) | Physical functioning, illness-related fears, psychosocial functioning, and pain | 16 | ≥ 18 | Postmenopausal osteoporosis | |
Osteoporosis Assessment Questionnaire—Short Version (OPAQ) | Physical function, emotional status, symptoms and social interaction | 34 | ≥ 18 | Postmenopausal osteoporosis | [115] | |
Osteoporosis-Targeted Quality of Life (OPTQoL) | Physical difficulty, adaptations and fears | 32 | ≥ 18 | Female osteoporosis | [116] | |
Osteoporosis Quality of Life Questionnaire (OQLQ) | Symptoms, physical function, activities of daily living, emotional function and leisure | 30 | ≥ 18 | Female osteoporosis | [117] | |
Mini-Osteoporosis Quality of Life Questionnaire (Mini-OQLQ) | Symptoms, physical function, activities of daily living, emotional function and leisure | 10 | ≥ 18 | Postmenopausal osteoporosis | [118] | |
Quality of Life in Osteoporosis (Qualiost) | Physical and emotional | 23 | ≥ 18 | Osteoporosis | [119] | |
Seizures | Epilepsy & Learning Disabilities Quality of Life Questionnaire (ELDQOL) | Behavior, seizure activity, mood and side effects | 70 | 0–18 | Epilepsy and learning disabilities, Dravet syndrome | |
Quality Of Life In Epilepsy (QOLIE-10/QOLIE-10-P) | Epilepsy effects, mental health, role function | 10/11 | ≥ 18 | Epilepsy | [122] | |
Quality Of Life In Epilepsy (QOLIE-31) | Seizure worry, overall QOL, emotional wellbeing, energy/fatigue, cognitive functioning, medication effects, social functioning | 31 | ≥ 18 | Epilepsy | [123] | |
Quality of Life in Epilepsy Inventory for Adolescents (QOLIE-AD-48) | Epilepsy impact, memory-concentration, attitudes towards epilepsy, physical function, stigma, social support, school behavior, health perception | 48 | 11–17 | Epilepsy | [124] | |
Quality of Life in Childhood Epilepsy Questionnaire (QOLCE) | Physical restrictions, energy/fatigue, attention/concentration, memory, language, other cognitive processes, depression, anxiety, control/helplessness, self-esteem, social interactions, social activities, stigma, behaviour, general health, and quality of life | 91 | 4–18 | Epilepsy | [125] | |
Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55) | Cognitive, emotional, physical and social functioning | 55 | 4–12 | Epilepsy | [126] | |
Sleep disturbances | Insomnia Severity Index (ISI) | Initial (sleep-onset), middle (sleep maintenance), terminal (awakening), satisfaction, interference (with daily functioning), noticeability and distress | 7 | ≥ 18 | Insomnia | [127] |
Pittsburgh Insomnia Rating Scale (PIRS)-20 | Nighttime and daytime distress symptoms, sleep parameters, quality, regularity, and depth of sleep | 20 | ≥ 18 | Diabetes mellitus type II and insomnia | [128] | |
Several signs/symptoms | Cushing QoL Questionnaire (CushQoL) | Daily life, emotional, and physical aspects | 12 | ≥ 18 | Cushing syndrome | [129] |
University of Washington Quality of Life Questionnaire (UW-QOL) | Pain, appearance, activity, recreation, swallowing, chewing, speech, shoulder, taste, saliva, mood and anxiety | 12 | ≥ 18 | Head and neck cancer | [130] | |
University of California Los Angeles Prostate Cancer Index (UCLA-PCI) | Urinary, sexual and bowel function, urinary, sexual and bowel bother | 20 | ≥ 18 | Early state of prostate cancer | [131] |